These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32930639)

  • 21. Amide Moieties Modulate the Antimicrobial Activities of Conjugated Oligoelectrolytes against Gram-negative Bacteria.
    Limwongyut J; Moreland AS; Nie C; Read de Alaniz J; Bazan GC
    ChemistryOpen; 2022 Feb; 11(2):e202100260. PubMed ID: 35133087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of Antimicrobial Resistance and Virulence Genes within the Prophage-Associated Regions in Nosocomial Pathogens.
    Kondo K; Kawano M; Sugai M
    mSphere; 2021 Aug; 6(4):e0045221. PubMed ID: 34232073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A broad-spectrum synthetic antibiotic that does not evoke bacterial resistance.
    Heithoff DM; Mahan SP; Barnes V L; Leyn SA; George CX; Zlamal JE; Limwongyut J; Bazan GC; Fried JC; Fitzgibbons LN; House JK; Samuel CE; Osterman AL; Low DA; Mahan MJ
    EBioMedicine; 2023 Mar; 89():104461. PubMed ID: 36801104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ESKAPEing the labyrinth of antibacterial discovery.
    Tommasi R; Brown DG; Walkup GK; Manchester JI; Miller AA
    Nat Rev Drug Discov; 2015 Aug; 14(8):529-42. PubMed ID: 26139286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial peptides (AMPs): a patent review (2015-2020).
    Annunziato G; Costantino G
    Expert Opin Ther Pat; 2020 Dec; 30(12):931-947. PubMed ID: 33187458
    [No Abstract]   [Full Text] [Related]  

  • 27. Eliciting antibiotics active against the ESKAPE pathogens in a collection of actinomycetes isolated from mountain soils.
    Zhu H; Swierstra J; Wu C; Girard G; Choi YH; van Wamel W; Sandiford SK; van Wezel GP
    Microbiology (Reading); 2014 Aug; 160(Pt 8):1714-1725. PubMed ID: 24794971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine-Tuning of Alkaline Residues on the Hydrophilic Face Provides a Non-toxic Cationic α-Helical Antimicrobial Peptide Against Antibiotic-Resistant ESKAPE Pathogens.
    Luo X; Ye X; Ding L; Zhu W; Yi P; Zhao Z; Gao H; Shu Z; Li S; Sang M; Wang J; Zhong W; Chen Z
    Front Microbiol; 2021; 12():684591. PubMed ID: 34335511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bactericidal efficacy of atmospheric pressure non-thermal plasma (APNTP) against the ESKAPE pathogens.
    Flynn PB; Higginbotham S; Alshraiedeh NH; Gorman SP; Graham WG; Gilmore BF
    Int J Antimicrob Agents; 2015 Jul; 46(1):101-7. PubMed ID: 25963338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of ESKAPE Bacterial Pathogens at the Point of Care Using Isothermal DNA-Based Assays in a Portable Degas-Actuated Microfluidic Diagnostic Assay Platform.
    Renner LD; Zan J; Hu LI; Martinez M; Resto PJ; Siegel AC; Torres C; Hall SB; Slezak TR; Nguyen TH; Weibel DB
    Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens.
    Du H; Puri S; McCall A; Norris HL; Russo T; Edgerton M
    Front Cell Infect Microbiol; 2017; 7():41. PubMed ID: 28261570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections.
    Younis W; Thangamani S; Seleem MN
    Curr Pharm Des; 2015; 21(28):4106-11. PubMed ID: 25961308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms.
    Reffuveille F; de la Fuente-Núñez C; Mansour S; Hancock RE
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5363-71. PubMed ID: 24982074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Differences between E. coli and ESKAPE Pathogen GroES/GroEL.
    Sivinski J; Ambrose AJ; Panfilenko I; Zerio CJ; Machulis JM; Mollasalehi N; Kaneko LK; Stevens M; Ray AM; Park Y; Wu C; Hoang QQ; Johnson SM; Chapman E
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unlocking the bacterial membrane as a therapeutic target for next-generation antimicrobial amphiphiles.
    Mehta D; Saini V; Aggarwal B; Khan A; Bajaj A
    Mol Aspects Med; 2021 Oct; 81():100999. PubMed ID: 34325929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective Analysis on Antimicrobial Resistance Trends and Prevalence of β-lactamases in
    Nasser M; Palwe S; Bhargava RN; Feuilloley MGJ; Kharat AS
    Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33096921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in tackling microbial multidrug resistance with essential oils: combinatorial and nano-based strategies.
    Trifan A; Luca SV; Greige-Gerges H; Miron A; Gille E; Aprotosoaie AC
    Crit Rev Microbiol; 2020 May; 46(3):338-357. PubMed ID: 32608293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial resistance of selected invasive bacteria in a tertiary care center: results of a prospective surveillance study.
    Djuric O; Jovanovic S; Stosovic B; Tosic T; Jovanovic M; Markovic-Denic L
    J Infect Dev Ctries; 2016 Dec; 10(12):1325-1331. PubMed ID: 28036312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.